Increased circulating asymmetric dimethylarginine (ADMA) levels in active stage of Behçet’s Syndrome
No Thumbnail Available
Date
2009
Journal Title
Journal ISSN
Volume Title
Publisher
Thieme Publishing Group
Access Rights
info:eu-repo/semantics/openAccess
Abstract
There is little evidence in the literature about circulating asymmetric dimethylarginine (ADMA) levels in Behçet's syndrome (BS). The aim of the present study was 1. to measure the levels of ADMA in male patients with BS, 2. to compare ADMA levels with healthy volunteers, and 3. to evaluate whether there is any difference between patients both with / without thrombosis and in active / inactive stage. In patients with BS, CRP levels were higher than controls. The mean ADMA and C-reactive protein (CRP) levels were significantly higher in active stage patients and patients with thrombosis than in patients during the inactive stage and without thrombosis. In conclusion, we did not find any significant difference in ADMA levels between patients with BS and healthy controls. Serum ADMA concentrations, however,
Description
Keywords
Behçet's disease, asymmetric dimethylarginine, endothelial dysfunction, thrombosis, active stage
Journal or Series
Aktuelle Rheumatologie
WoS Q Value
Scopus Q Value
Q4
Volume
34
Issue
2
Citation
Terekeci, M. H., Nalbant, S., Özgürtaş, T., Çelik, S., Tapan, S., Sanisoğlu, Y. S., Şahan, B., Sayan, Ö., Küçükardalı, Y., Top, C. ve Öktenli, Ç. (2009). Increased circulating asymmetric dimethylarginine (ADMA) levels in active stage of Behçet’s Syndrome. Aktuelle Rheumatologie, Thieme Publishing Group. 34(2), s. 121-125.
